Salman Khan, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5801 Bremo Rd, Richmond, VA 23226 Phone: 804-287-7270 Fax: 804-285-0726 |
Dr. Abdullah Khan, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 9131 Stony Point Pkwy Apt 3104, Richmond, VA 23235 Phone: 678-612-0138 |
Mr. Javed Akram, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 7101 Jahnke Rd Ste 611, Virginia Hospitalist, Richmond, VA 23225 Phone: 804-327-4046 |
William A Thistlethwaite, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5801 Bremo Rd, Richmond, VA 23226 Phone: 804-287-7270 Fax: 804-285-0726 |
Jonathan A. Segars, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 1300 E Marshall St, Richmond, VA 23298 Phone: 804-828-3144 Fax: 804-628-7104 |
Abreham Baye Feleke, MD Hospitalist Medicare: Not Enrolled in Medicare Practice Location: Mcguire Va Medical Center 1201 Broad Rock Blvd, Richmond, VA 23249 Phone: 804-675-5000 |
Ishan Bhovanbhai Patel, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1602 Skipwith Rd, Richmond, VA 23229 Phone: 804-289-4500 |
Nelson Enor Airewele, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5801 Bremo Rd, Richmond, VA 23226 Phone: 804-287-7270 Fax: 804-285-0726 |
Chanda Yaqub, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 5801 Bremo Rd, Richmond, VA 23226 Phone: 804-287-7270 Fax: 804-285-0726 |
Myra Nasir, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 1300 E Marshall St, Richmond, VA 23298 Phone: 804-828-3144 Fax: 804-628-7104 |
Dharmeshbhai Ravjibhai Sanghani, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 5801 Bremo Rd, Richmond, VA 23226 Phone: 804-287-7270 |
Manaye Kebede, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 1602 Skipwith Rd, Richmond, VA 23229 Phone: 804-289-4500 |
Iman Mohamoud Ibrahim, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1300 E Marshall St, Richmond, VA 23298 Phone: 804-828-3144 Fax: 804-628-7104 |
Srivani Angadala, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 1250 E Marshall St, Richmond, VA 23298 Phone: 804-828-9783 |
Dr. Ryan Jeffrey Zeigler, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 1250 E Marshall St # 980163, Richmond, VA 23298 Phone: 804-828-8865 |
News Archive
"I have spent my career seeking to understand and tackling deadly viruses, from ebola to HIV. But polio stands out because, unlike these diseases, we already hold the key to its eradication: effective vaccines," Peter Piot, director and professor of global health at the London School of Hygiene and Tropical Medicine, writes in The Guardian's "Poverty Matters" blog.
By snipping out and analyzing tiny samples of patients' tonsils, scientists have identified a key cellular checkpoint that is somehow bypassed in lupus patients, where harmful immune cells that normally are squelched by the body are mistakenly granted access.
Inovio Pharmaceuticals, Inc. announced today that in a preclinical study with two animal models, Inovio's hTERT (human telomerase reverse transcriptase) DNA cancer vaccine administered with Inovio's CELLECTRA adaptive electroporation delivery technology generated robust and broad immune responses, broke the immune system's tolerance to its self-antigens, induced T-cells with a tumor-killing function, and increased the rate of survival.
Alzheimer's disease (AD) progresses inside the brain in a rising storm of cellular chaos as deposits of the toxic protein, amyloid-beta (Aβ), overwhelm neurons. An apparent side effect of accumulating Aβ in neurons is the fragmentation of the Golgi apparatus, the part of the cell involved in packaging and sorting protein cargo including the precursor of Aβ. But is the destruction the Golgi a kind of collateral damage from the Aβ storm or is the loss of Golgi function itself part of the driving force behind Alzheimer's? This was the question for Yanzhuang Wang, Gunjan Joshi, and colleagues at the University of Michigan, Ann Arbor, as they set out to uncover the mechanism damaging the Golgi, using a transgenic mouse and tissue culture models of AD to look at what was going on.
Ligand Pharmaceuticals Incorporated today announced that its partner GlaxoSmithKline has announced that it received positive data from ENABLE-1, the first of two Phase III studies examining Promacta in patients with hepatitis C-related thrombocytopenia, and that full data will be released at an upcoming scientific conference.
› Verified 2 days ago